The most common therapy for FVIII inhibitor eradication in AHA is steroids, alone (PSL 1–2 mg/kg/day for 4–6 weeks) or in combination with cyclophosphamide (1–2 mg/kg/day for a maximum of 5 weeks).[1,2] These therapies can achieve CR in 70% to 80% of AHA patients.[1] In the current case, the patient could be treated by PSL alone. Here, F8 is linked to autoimmune hemolytic anemia.